PURPOSE:
This presentation offers a reflective account of my journey as both a consumer and donor of Anti-D immunoglobulin, aiming to humanise the therapy and provide midwives with a deeper understanding of its historical, ethical, and personal dimensions. By sharing my unique perspective, I hope to foster empathy and enhance communication between midwives and the individuals they care for, improving informed decision-making around Anti-D administration.

DISCUSSION:
I recount my experience as a Rhesus negative mother receiving Anti-D, initially without fully understanding the therapy, and my later pursuit of more informed choices during subsequent pregnancies. This reflection extends to my participation in the Anti-D donor program, including the challenging process of intentional isoimmunisation. The journey from passive recipient to active donor underscores the emotional and ethical complexities inherent in the Anti-D program, providing a rare perspective that combines clinical practice with lived experience.

EVIDENCE WHERE RELEVANT:
Approximately 16% of Australians are Rhesus negative, and Anti-D therapy plays a critical role in preventing haemolytic disease of the foetus and newborn. Despite its widespread use, many consumers struggle to access clear, balanced information about the therapy. The development of Anti-D immunoglobulin was made possible by groundbreaking research, including early studies involving human trials, which paved the way for today’s life-saving treatments. This historical context is essential for understanding how scientific research continues to shape and improve maternity care.

KEY MESSAGE:
Research has laid the foundation for today’s Anti-D therapy, and understanding its history enriches the practice of midwifery. This presentation aims to deepen midwives’ empathy, enhance their communication with clients, and highlight the ongoing need for research, innovation, and blood donation to ensure the continued success of this essential medical intervention. Poster session 4 (Group B)